Data / Drug companies / Ondansetron hydrochloride
Ondansetron hydrochloride: 48 companies and 101 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Ondansetron hydrochloride is listed in the FDA National Drug Code Directory by 48 companies, with 101 products in commercial distribution. 101 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; solution; injection, solution, and the newest product started marketing on August 14, 2026.
The request: Get every company that lists ondansetron hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 48
- Products
- 101
- Generic (ANDA) products
- 101 (100.0%)
- Application numbers
- 17
- Routes
- Oral, Intramuscular, Intravenous
- Brand names
- Ondansetron, Ondansetron, Ondansetron
- openFDA record search
- api.fda.gov
Companies that list ondansetron hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| NuCare Pharmaceuticals,Inc. | 7 | tablet, film coated; solution | Generic drugs (ANDA) | November 28, 2007 |
| Bryant Ranch Prepack | 5 | tablet, film coated | Generic drugs (ANDA) | July 31, 2007 |
| A-S Medication Solutions | 4 | tablet, film coated | Generic drugs (ANDA) | July 31, 2007 |
| Aurobindo Pharma Limited | 4 | tablet, film coated; solution | Generic drugs (ANDA) | November 28, 2007 |
| Dr. Reddy's Laboratories Limited | 4 | tablet, film coated | Generic drugs (ANDA) | December 26, 2006 |
| Northwind Health Company, LLC | 4 | tablet, film coated | Generic drugs (ANDA) | August 8, 2022 |
| Preferred Pharmaceuticals Inc. | 4 | tablet, film coated | Generic drugs (ANDA) | April 29, 2024 |
| Asclemed USA, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | July 31, 2007 |
| Cardinal Health 107, LLC | 3 | tablet, film coated; solution | Generic drugs (ANDA) | May 5, 2025 |
| Phoenix RX LLC | 3 | tablet, film coated | Generic drugs (ANDA) | July 31, 2007 |
| Proficient Rx LP | 3 | tablet, film coated | Generic drugs (ANDA) | July 31, 2007 |
| QPharma, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | July 31, 2007 |
| Remedyrepack Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | July 18, 2024 |
| St. Mary's Medical Park Pharmacy | 3 | tablet, film coated | Generic drugs (ANDA) | July 24, 2026 |
| American Health Packaging | 2 | tablet, film coated | Generic drugs (ANDA) | September 21, 2023 |
| AvPAK | 2 | tablet, film coated | Generic drugs (ANDA) | August 5, 2016 |
| Bryant Ranch Prepack | 2 | tablet, film coated | Generic drugs (ANDA) | July 31, 2007 |
| Eugia US LLC | 2 | injection, solution | Generic drugs (ANDA) | December 21, 2012 |
| Fresenius Kabi USA, LLC | 2 | injection, solution | Generic drugs (ANDA) | May 31, 2022 |
| Fresenius Kabi USA, LLC | 2 | injection | Generic drugs (ANDA) | November 18, 2009 |
| Ipca Laboratories Limited | 2 | tablet, film coated | Generic drugs (ANDA) | August 14, 2026 |
| Major Pharmaceuticals | 2 | tablet, film coated | Generic drugs (ANDA) | December 26, 2006 |
| Onesource Specialty Pharma Limited | 2 | injection | Generic drugs (ANDA) | September 30, 2023 |
| Quality Care Products, LLC | 2 | tablet, film coated | Generic drugs (ANDA) | May 25, 2018 |
| Rising Pharma Holdings, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | July 31, 2007 |
| Sportpharm LLC | 2 | tablet, film coated | Generic drugs (ANDA) | July 31, 2007 |
| Sun Pharmaceutical Industries, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | June 25, 2007 |
| Unit Dose Solutions, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | July 8, 2026 |
| Aphena Pharma Solutions - Tennessee, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | July 31, 2007 |
| Ascend Laboratories, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | January 6, 2007 |
| Atlantic Biologicals Corp. | 1 | solution | Generic drugs (ANDA) | November 28, 2007 |
| Baxter Healthcare Corporation | 1 | solution | Generic drugs (ANDA) | March 13, 2013 |
| Chartwell Governmental & Specialty RX, LLC. | 1 | solution | Generic drugs (ANDA) | January 27, 2011 |
| Chartwell RX, LLC | 1 | solution | Generic drugs (ANDA) | January 27, 2011 |
| Coupler LLC | 1 | tablet, film coated | Generic drugs (ANDA) | June 16, 2026 |
| Fresenius Kabi USA, LLC | 1 | injection | Generic drugs (ANDA) | November 18, 2009 |
| Hikma Pharmaceuticals USA Inc. | 1 | solution | Generic drugs (ANDA) | December 26, 2006 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 1 | tablet, film coated | Generic drugs (ANDA) | December 26, 2006 |
| NorthStar Rx LLC | 1 | solution | Generic drugs (ANDA) | November 28, 2007 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | July 31, 2007 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | July 31, 2007 |
| PharmPak, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | August 8, 2019 |
| Precision Dose, Inc. | 1 | solution | Generic drugs (ANDA) | February 27, 2015 |
| Proficient Rx LP | 1 | tablet, film coated | Generic drugs (ANDA) | July 31, 2007 |
| Proficient Rx LP | 1 | tablet, film coated | Generic drugs (ANDA) | July 31, 2007 |
| Quality Care Products, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | July 25, 2024 |
| Redpharm Drug | 1 | tablet, film coated | Generic drugs (ANDA) | July 31, 2007 |
| Sagent Pharmaceuticals | 1 | injection, solution | Generic drugs (ANDA) | August 30, 2012 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 81 | 80.2% |
| Solution | 10 | 9.9% |
| Injection, solution | 5 | 5% |
| Injection | 5 | 5% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 101 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Serotonin-3 Receptor Antagonist | 101 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.